October Pharma S.A.E announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was EGP 543.397 million compared to EGP 523.114 million a year ago. Operating income was EGP 145.095 million compared to EGP 98.559 million a year ago. Net income was EGP 88.258 million compared to EGP 33.827 million a year ago. Basic earnings per share from continuing operations was EGP 14.71 compared to EGP 5.64 a year ago.